Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹89 Cr₹48 Cr₹83 Cr₹35 Cr₹242 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹89 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr
Mar2021₹35 Cr
Mar2020₹242 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr
137.32
Mar2021 ₹35 Cr
-85.60
Mar2020 ₹242 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,592.6 Cr -0.6% 7.9% 6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,910.0 Cr 5.4% 3.2% 20.4% Stock Analytics
DIVIS LABORATORIES ₹160,035.0 Cr 1.9% 2% 59.4% Stock Analytics
CIPLA ₹125,540.0 Cr 1.7% 2% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,894.0 Cr 2.8% 2.3% 22.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,110.0 Cr 2.1% -0.9% -1.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.6%

7.9%

6.6%

SENSEX

1%

4.3%

8.9%


You may also like the below Video Courses